Laura Weinstein | Drug Delivery Systems | Best Researcher Award

Laura Weinstein | Drug Delivery Systems | Best Researcher Award

Ms. Laura Weinstein, University of Delaware, United States

Ms. Laura Weinstein is an accomplished biomedical engineering student at the University of Delaware πŸŽ“, set to graduate in May 2025 with a stellar GPA of 3.97. With minors in nanoscale materials and chemistry πŸ§ͺ, she has led impactful research in nanoparticle drug delivery, orthotic device innovation, and immunoengineering. Her work spans labs at Delaware and Vanderbilt πŸ₯, earning her top honors including the Eugene du Pont Memorial Scholarship and Best Poster Awards πŸ†. Passionate about translational medicine, Laura’s dedication to improving healthcare through engineering solutions marks her as a rising star in biomedical research 🌟.

Publication ProfileΒ 

Google Scholar

Education

Ms. Laura Weinstein is currently pursuing an Honors Bachelor of Science in Biomedical Engineering at the University of Delaware, with expected graduation in May 2025 πŸ“…. She maintains an outstanding GPA of 3.97 🌟 and complements her major with minors in Nanoscale Materials and Chemistry βš—οΈ. Her coursework spans core sciences and advanced engineering, including Introductory Biology 🧬, General Chemistry πŸ§ͺ, Physics βš›οΈ, and Biomedical Experimental Design πŸ“Š. She has also delved into Immunoengineering, Cell Engineering 🧫, Nanomaterials, and Nanomedicine πŸ’‰. Proficient in Python and MATLAB πŸ’», Laura combines technical skills with scientific curiosity, preparing her for groundbreaking biomedical research πŸ”¬.

Awards

Ms. Laura Weinstein has received numerous prestigious honors throughout her academic journey. From 2021–2025, she was awarded the esteemed Eugene du Pont Memorial Scholarship πŸŽ“, covering full tuition, housing, meals, and book expenses. In 2024, she earned 1st place for designing a prototype to secure thoracostomy tubes 🩺. She is also a National Cyber Scholar (2022–2024) πŸ’» and won the Biomedical Engineering Distinguished Sophomore Award in 2023 🧬. That same year, she was recognized by the Delaware Department of Technology and Information πŸ“‘. In 2022, she placed 1st in the Ratcliffe Eco Entrepreneurship Innovation Sprint πŸŒ±πŸš€

Experience

Ms. Laura Weinstein has been actively engaged in cutting-edge research at the University of Delaware’s Day Lab since January 2022 πŸ›οΈ. Under the mentorship of Dr. Emily Day and PhD candidate Eric Sterin πŸ‘©β€πŸ«, she developed polymeric nanoparticles for biomimetic cargo delivery via cancer cell membranes 🧫. She contributed to refining purification protocols for DiD-fluorescent nanoparticles πŸ’‘ and guided fellow undergraduates in research techniques πŸ“˜. Her dedication extended beyond semesters, participating in multiple research fellowships and programs including the 2022 CBER Summer Scholars REU, 2023 Winter Fellowship, and 2024–2025 Summer/Winter Fellowships πŸ§ͺπŸ“Šβ€”highlighting her passion for biomedical innovation.

Research Focus

Ms. Laura Weinstein focuses her research in the dynamic field of biomedical nanotechnology and targeted drug delivery πŸ§ͺ. Her studies explore cell biomimicry, using cancer cell membranes to improve therapeutic delivery for hematological cancers 🧫🩸. She also investigates nanoparticle purification challenges, ensuring enhanced precision in drug transport systems 🎯. Her work integrates principles of nanomedicine, immunoengineering, and materials science to develop innovative approaches in cancer treatment and diagnostics 🧬. Through her publications and lab experience, Laura contributes to advancing next-generation polymeric nanoparticle technologiesβ€”blending engineering and biology to revolutionize patient care and medical outcomes πŸš€πŸ’Š.

Publication Top Notes

Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes

Standard purification methods are not sufficient to remove micellular lipophilic dye from polymer nanoparticle solution

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Dr. nisreen kaddim, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nisreen Kaddim Radi is an Assistant Professor at the University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🧬. Her research focuses on antimicrobial resistance, food safety, and innovative antibacterial films for medical applications πŸ₯. She has presented at international conferences and published extensively in high-impact journals πŸ“š. Passionate about advancing science, she integrates computational and experimental approaches to explore anticancer and antibacterial agents βš—οΈ. With a commitment to research and education, Dr. Nisreen inspires students and contributes to scientific innovation 🌍.

Publication Profile

Google Scholar

Professional Background

Dr. Nisreen Kaddim Radi πŸŽ“ is an Assistant Professor at the College of Science for Women, University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🦠, with a focus on food safety and packaging 🍱. She is a member of the Arab Association for Science and Technology, Iraq branch, and serves on the Educational Guidance Committee at her college. Dr. Nisreen has published numerous research papers and actively participates in global conferences 🌍, including the 2022 International Conference on Sustainable Development Goals in Istanbul, ICAB 2022 at the University of Basrah, and ICAB2 2024, where she presented her studies on antimicrobial resistance, genetic variation, and immunological research

Memberships

Dr. Nisreen Kaddim Radi πŸ”¬ is a dedicated researcher with significant contributions to molecular biology, genetics, and virology 🧬. Although she does not hold editorial positions or industry collaborations, her active engagement in scientific research strengthens her impact in the field. As a member of the Arab Association for Science and Technology 🌍, she remains connected to a network of experts, enhancing her academic and professional credibility. Through her research and participation in international conferences, Dr. Nisreen continues to contribute valuable insights to the scientific community, particularly in food safety and antimicrobial resistance 🦠.

Innovation in Methodology

Dr. Nisreen Kaddim Radi πŸ”¬ combines computational simulations with experimental studies to develop innovative methods for enhancing the effectiveness of antibacterial and anticancer agents πŸ¦ πŸŽ—οΈ. Her dual-approach methodology integrates cutting-edge technology with practical applications, demonstrating a high level of scientific innovation πŸš€. By bridging computational modeling with real-world experimentation, she contributes to advancing medical and pharmaceutical research, aligning perfectly with the award’s objectives πŸ†. Her work not only improves therapeutic outcomes but also paves the way for more efficient and targeted treatments, reinforcing her role as a leading researcher in molecular biology and biotechnology 🧬.

Research Excellence

Dr. Nisreen Kaddim Radi πŸ”¬ is pioneering the development of antibacterial films by integrating nanomaterials, polymers, and plant extracts 🌱🦠. Her innovative approach has profound implications for both medical and industrial applications πŸ₯🏭, positioning her at the forefront of antibacterial and anticancer material research πŸŽ—οΈ. Her groundbreaking study, Integrative Computational and Experimental Study of Propolis, Polyvinyl Alcohol, and Alhagi maurorum Complex as Anticancer and Antibacterial Agents πŸ“œ, showcases a multidisciplinary methodology, blending computational modeling with experimental validation πŸ’»βš—οΈ. This research enhances therapeutic potential, contributing to the advancement of novel biomedical materials and precision-targeted treatments πŸš€.

Research Focus

Dr. Nisreen Kaddim Radi’s research primarily focuses on medical microbiology 🦠, immunology 🧬, and infectious diseases πŸ₯. Her work extensively explores viral infections such as Varicella Zoster Virus (VZV) 🏡️, Human Papillomavirus (HPV) πŸŽ—οΈ, and Hepatitis B Virus (HBV) 🦠, investigating genetic susceptibility and immune response. She also examines bacterial resistance 🧫, particularly in foodborne pathogens like E. coli, and studies immunological markers πŸ§ͺ in various infections. Her contributions in genetic polymorphisms πŸ”¬, cytokine responses 🌑️, and molecular typing of pathogens highlight her expertise in understanding disease mechanisms and improving diagnostic approaches in infectious diseases and immunological disorders.